Brenda Ohnuki
Professional
Professional experience
Brenda is a member of the Life Sciences & Healthcare team, with experience in both advisory and contentious matters within the healthcare sector. She advises clients on regulatory issues involving ANVISA and MAPA, supporting a range of stakeholders in regulated industries, including M&A transactions and due diligence processes, as well as contractual, administrative and judicial matters, always adopting a business-focused legal approach.
Education
- LL.B. Bachelor of Laws from Universidade Presbiteriana Mackenzie – 2023 (Brazil)
- Project Management Diploma from Australian Pacific College – 2025 (Australia)
Publications
- “Factual News: How to Act Lawfully”, Thoth Publishing, 2023. Chapter: “Judicialization of Health: The Provision of Off-Label Medications by the State”.
- “The Regulatory Framework of Cannabis sativa and Its Derivatives Remains Under Debate in the National Congress”, Estadão (Fausto Macedo’s Blog), July 2021.
related content
-

News
INAEP Public Consultation on Administrative Appeals Seeks to Bring Predictability to the New Research Ethics System
12/11/2026
-

News
INAEP Public Consultation Signals a Paradigm Shift in the Risk Classification of Research Involving Human Participants
12/11/2026
-

News
Anvisa Expands e-Notivisa to Include Technical Complaints Related to Medicines
06/11/2026


